MENU
ARGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

argenx SE (ARGX) Ownership - Who owns argenx SE?

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

Profile

Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
3522
Web
https://www.argenx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
60.12B
P/E Ratio
37.04
Total Cash
5.18B
Projected Growth
1.19
Total Debt
47M
Revenue
5.23B
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash/Share
82.86
Total Debt/Equity
N/A
Revenue/Share
79.92 USD as % of share price
Who owns argenx SE? ARGX symbol Ownership - Tickeron.com